weight loss drug news today glp-1 september 2025 GLP-1s for Small Amounts of Loss? Doctors Say Yes One of the fastest growing
Description
The diabetes medications category provides a broader view of tablets and other therapies
Niedereichholz U
Renal insufficiency, chronic
The study found increased risk in both patients with type 2 diabetes and patients using semaglutide for overweight or obesity, but the authors noted that the study was observational and could not prove that semaglutide directly caused NAION
[DOI] [PubMed] [Google Scholar] 873.Driessen J.H., Henry R.M., van Onzenoort H.A., Lalmohamed A., Burden A.M., Prieto-Alhambra D
